Cobo Technologies

PIPPR Project on CRISPR Base-Editors (ABE)


Great presentation by Roberto Nitsch, Safety Director, AstraZeneca at the NIST - Genome Editing Consortium Workshop 3rd May 2019 in US, on the idea behind their PIPPR project to understand the impact of CRISPR Base-Editors (ABE) on proteomic level.

PIPPR® is the first platform that offer the gene editing scientist an extensive and detailed protein expression analysis solution for any cells modified with CRISPR, ZFN or TALENs.

PIPPR® is powered by SWATH LC-MS, which gives you label-free proteome scale identification and quantification of any the protein in your cell.

Read more about PIPPR here.

Sign-Up COBO-Q Newsletter and receive the latest updates within Quality Control Genome Editing.

By using this website, you agree to the use of cookies to give you the best user experience.
Find additional information at Cookies